When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RVNC - Revance Therapeutics rises as company insider buys share worth ~$430K
Revance Therapeutics Inc.
Revance Therapeutics (RVNC +10.7%) shares are on the rise after Aubrey Rankin, President of Innovation & Tech, purchased 30,000 company shares, worth ~$430K. The shares were purchased at $14.33 - $14.50 in a transaction dated Dec 03, 2021. Form 4 A look at Revance Therapeutics' ownership structure: RVNC is down 48.55% YTD. The biotechnology firm also recently disclosed a purchase of 40K shares by CEO Mark Foley.